Fintel reports that on October 29, 2025, BTIG reiterated coverage of Innate Pharma S.A. - Depositary Receipt (NasdaqGS:IPHA) with a Buy recommendation. As of September 30, 2025, the average one-year ...
Innate Pharma SA IPHA announced that the FDA lifted the partial clinical hold placed on the lacutamab investigational new drug (IND) in October 2023. Innate Pharma’s lead proprietary program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results